Why patients love Semaglutide: Proven track record and FDA-approved for weight loss Helps reduce appetite and cravings Can support long-term weight management with lifestyle changes Understanding Tirzepatide Tirzepatide is one of the newest medications available and its making a big impact
Because MCC is fast-growing cancer, it can be hard to treat if it spreads to areas beyond the skin
Date, time, units drawn, concentration, milligrams administered, injection site
Is Sofwave suitable for post-GLP-1 patients in a medical setting

Patient Assessment Protocol Comprehensive medical history with obesity-specific screening Physical examination including BMI, waist circumference, and body composition analysis Laboratory workup: complete metabolic panel, lipid panel, HbA1c, thyroid function, insulin levels Screening for sleep apnea, PCOS, Cushing syndrome, and other secondary causes of obesity Mental health screening for binge eating disorder and depression Readiness-to-change assessment Medication Formulary for Your Medical Weight Loss Program GLP-1 receptor agonists: Semaglutide (Wegovy), liraglutide (Saxenda), tirzepatide (Zepbound) Sympathomimetic agents: Phentermine (short-term), phentermine/topiramate (Qsymia) Other FDA-approved options: Naltrexone/bupropion (Contrave), orlistat (Xenical/Alli) Off-label considerations: Metformin, topiramate, bupropion (when clinically appropriate and properly documented) Your medical weight loss program's protocols should specify prescribing criteria, dosing escalation schedules, monitoring requirements, and discontinuation criteria for each medication
